Scientific Advisory Boards Of Biosymetrics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail
IMAGE: Senior author and Princess Margaret Scientist Dr. Marianne Koritzinsky s research reveals the potential of targeted therapies to exploit unique metabolic features of pancreatic cancer cells.
view more 
Credit: Visual Services, UHN
(Toronto, Friday, May 7, 2021) Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.
Led by Princess Margaret Cancer Centre (PM) Scientist Dr. Marianne Koritzinsky, researchers showed that about half of patient-derived pancreatic cancer cell lines are highly dependent or addicted to the protein peroxiredoxin 4 (PRDX4), as a result of the altered metabolic state of the cancer cell. ....

United States , Alexandra Radkewycz , Marianne Koritzinsky , Pionyr Immunotherapeutics , Bradlyg Wouters , David Hedley , Jason Moffat , Paulc Boutros , University Health Network , Scientific Advisory Boards Of Biosymetrics Inc , Michener Institute For Education , Terry Fox Foundation Research Institute , Senior Public Affairs Advisor , University Of Toronto , American Association For The Advancement Of Science , Institute Of Medical Science , Ontario Ministry Of Health , Princess Margaret Cancer Centre Pm Scientist Dr , Donnelly Centre For Cellular , Toronto Rehabilitation Institute , Princess Margaret Cancer Foundation , Intersect Diagnostics Inc , Biomolecular Research , Princess Margaret Cancer Centre , Cancer Research Society Robert Letterman Memorial Fund , Science Advances ,